Doxycycline Tablets And Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets and Capsules
Available Strengths: 100 mg, 50 mg
Reference Brands: Vibramycin(EU & US)
Category:
Antibiotics
Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA attachment. It effectively treats respiratory, urinary, and skin infections. Benefits include broad-spectrum activity, good oral absorption, and anti-inflammatory properties, making it useful for acne, tick-borne diseases, and other bacterial infections.
Doxycycline tablets and capsules is available in Oral Tablets and Capsules
and strengths such as 100 mg, 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Doxycycline tablets and capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxycycline tablets and capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Doxycycline tablets and capsules are approved in the EU and US for treating respiratory, urinary, skin, and tick-borne infections. In the EU, brands like Vibramycin and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For regulatory dossier assistance, compliance, and registration, visit PharmaTradz. We support seamless market access for doxycycline formulations, ensuring adherence to European and US standards for safe, effective antibacterial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing